Neurology

The Migraine page has been updated, including additional information about the perfusion CT findings in migraine.

The Intracranial hypotension page has been updated with additional information about the role of an epidural blood patch for post LP headache.

The Intracranial hypotension page has been updated with additional information about post LP headache.

The Stroke page has been updated with some additional information about migraine as a stroke mimic.

The section on treatment on the Migraine page has been updated, re-prioritised and simplified.

Ketamine has been added as a possible third line agent for seizure control to the Status epilepticus page, although evidence of efficacy for most other third line agents is higher.

The Stroke management page has been updated with new information about IV aspirin

The phrase ‘benign intracranial hypertension’ has been removed from the manual – as idiopathic (venous) intracranial hypertension may not be clinically benign.

The Idiopathic intracranial hypertension page has been updated – including venous sinus stenosis as the primary cause.

The Guillain Barre syndrome page has been revised and updated.

The Peripheral nervous system examination page has been updated with some additional information about Clonus.

The Investigation of SAH page has been updated with revised sensitivities of CT for SAH.

The Parkinson’s disease page has had a number of other updates.

The Neuroleptic malignant syndrome page has been updated with additional information about its differential diagnoses.

The Neuroleptic malignant syndrome page has been updated with additional information about its treatment.

The Neuroleptic malignant syndrome page has been updated with additional information about its complications.

The Neuroleptic malignant syndrome page has been updated with additional information about its natural history.

The Parkinson’s disease page has been updated and a segment on the emergency aspects has been added.

The Subarachnoid haemorrhage page has been updated with additional information about complications.

The Management of stroke page has been updated with some information about andexanet for the treatment of ICH in patients taking DOACs – there is insufficient evidence of benefit to recommend it at present. Future trials will need to be better designed than this one. Connolly, S. J., Sharma, M., Cohen, A. T. et al., … Read more